A great pharma product or service is no longer enough.
Success in today’s markets depends on proactive portfolio management or pipeline prioritization. Yet too many companies still take a reactive, revenue-based approach to portfolio strategy, missing key growth opportunities.
Larka’s portfolio strategy solutions help companies improve performance across their existing asset or service portfolios, pinpoint the right markets for growth, and identify areas for divestment or realignment.
Combining deep pharma and business expertise with our proprietary toolkit, we align our clients’ portfolios with their long-term objectives and define the most valuable mix of business segments and markets to drive sustained growth.
Portfolio strategy solutions, tailored to each client’s unique needs.
Our Approach to Portfolio Strategy
We provide tailored portfolio strategy solutions to help our clients make strategic decisions that drive growth, optimize resources, and enhance competitive positioning.
- Therapeutic Area, Clinical Assets & Market Selection: Identify high-value indications, clinical assets and geographies for expansion.
- Pipeline Prioritization & Resource Allocation: Focus investments on the most promising assets based on market potential, competitive landscape, and regulatory pathways.
- Lifecycle Management & Commercial Strategy: Extend asset value through new indications, reformulations, and global market entry.
- Build vs. Buy Decision-Making: Assess internal development vs. partnerships, licensing, or M&A.
- Risk-Adjusted Portfolio Balancing: Optimize the mix of high-risk innovation and lower-risk, revenue-generating assets.
- Exit & Divestment Strategy: Identify underperforming assets and develop a strategy for divestment, out-licensing, or spin-offs.
- Service & Product Portfolio Expansion: Identify high-demand areas (e.g., modalities, geographies, technologies, adjacent capabilities) to strengthen offerings.
- Client Segmentation & Market Strategy: Define the most profitable customer segments and tailor commercial efforts.
- Capacity & Investment Planning: Align infrastructure, talent, and resources with future market demand.
- M&A & Strategic Partnerships: Assess acquisition and collaboration opportunities to expand capabilities and market reach.
- Pricing & Business Model Optimization: Develop competitive pricing strategies and scalable commercial models.
- Operational Efficiency & Scalability: Improve service delivery, cost efficiency, and profitability.
Trusted insights. Proven results.
- 50+
- Portfolio and Corporate Strategy projects completed each year
- 100+
- Clients served across the pharma ecosystem
- 90%
- Clients see stronger portfolio performance and market positioning after engagement
Let's give you the edge.
Unmatched pharma knowledge
We bring 30+ years of hands-on experience in the BioPharma industry, ensuring an unparalleled understanding of the unique challenges and opportunities within our client’s markets.
Cutting-edge tools
Our portfolio workstreams leverage AI-powered automation, advanced analytics, and proprietary market intelligence to optimize portfolios, prioritize investments, and stay ahead of industry shifts.
Tailored Portfolio Strategies
No two portfolios are the same. We design custom, data-driven portfolio strategies that align assets, investments, and markets to maximize value and long-term growth.
Global expert network
We collaborate with 500+ senior executives, innovators, leading academics, KOL and scientists to anticipate the trends shaping Pharma’s future—ensuring our portfolio strategies are grounded in real-world insights and forward-looking perspectives.
Portfolio strategy resources
Explore related capabilities
Ready to talk?
Get in touch with our experts in portfolio strategy